ロード中...
Development and Characterization of Orally Disintegrating Tablets Containing a Captopril-Cyclodextrin Complex
Captopril is the first angiotensin I-converting enzyme inhibitor widely used for the treatment of hypertension. Based on the well-known benefits of cyclodextrin inclusion complexes, the present study investigated the ability of β-cyclodextrin to include captopril. Solid inclusion complexes of captop...
保存先:
| 出版年: | Pharmaceutics |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7464127/ https://ncbi.nlm.nih.gov/pubmed/32784691 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics12080744 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|